Oncology Where old pathways to innovative cancer care fall short, a n... Ignoring half the people in the world cannot be good for business.
Views & Analysis The home advantage in cancer care The optimal cancer care pathway for this complex disease outside the hospital.
News Biogen, Ionis trumpet Alzheimer's data, but shares dip Biogen and Ionis have revealed the first clinical results with tau-targeting Alzheimer's drug candidate diranersen, to a mixed response.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.